Literature DB >> 7529310

Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein.

M Nakashima1, P M Vanhoutte.   

Abstract

Experiments were designed to determine how isoproterenol affects the cell membrane potential of smooth muscle cells of the canine saphenous vein. Measurements of membrane potential were performed using glass microelectrodes. Isoproterenol (10(-9) to 10(-6) M) caused sustained, concentration-dependent membrane hyperpolarizations in tissues with and without endothelium. ICI 118,551 (a selective beta 2-adrenoceptor antagonist), but not atenolol (a selective beta 1-adrenoceptor antagonist), abolished the hyperpolarization to isoproterenol. Forskolin, an activator of adenylate cyclase, produced sustained hyperpolarizations, which were not mimicked by 1,9-dideoxyforskolin. Incubation with either ouabain or extracellular K(+)-free solution did not inhibit the electrical response to isoproterenol. Glibenclamide (a selective ATP-sensitive K+ channel antagonist) attenuated the hyperpolarizations induced by either isoproterenol or forskolin, whereas charybdotoxin (an inhibitor of large conductance Ca(++)-activated K+ channels) did not. These findings suggest that isoproterenol opens ATP-sensitive K+ channels indirectly through activation of adenylate cyclase in the smooth muscle of the canine saphenous vein. The adrenergic receptor involved belongs to the beta 2-adrenoceptor subtype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529310

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  A(2A) adenosine receptor mediated potassium channel activation in rat epididymal smooth muscle.

Authors:  J M Haynes
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  beta-adrenoceptors and potassium channels.

Authors:  Albert Ferro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06       Impact factor: 3.000

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

5.  beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels.

Authors:  Detlef Bieger; Kakoli Parai; Carol Ann Ford; Reza Tabrizchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-25       Impact factor: 3.000

6.  Cantu syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms.

Authors:  Conor McClenaghan; Alex Hanson; Monica Sala-Rabanal; Helen I Roessler; Dragana Josifova; Dorothy K Grange; Gijs van Haaften; Colin G Nichols
Journal:  J Biol Chem       Date:  2017-12-22       Impact factor: 5.157

7.  The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings.

Authors:  N Satake; M Shibata; S Shibata
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed.

Authors:  M D Randall; A I McCulloch
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.

Authors:  Glaucia E Callera; Ester Yeh; Rita C A Tostes; Luciana C Caperuto; Carla R O Carvalho; Lusiane M Bendhack
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

Review 10.  Physiological roles of ATP-sensitive K+ channels in smooth muscle.

Authors:  Noriyoshi Teramoto
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.